Literature DB >> 11035425

Lamotrigine-induced lupus.

P Sarzi-Puttini1, B Panni, M Cazzola, S Muzzupappa, M Turiel.   

Abstract

A 57-year-old woman was under treatment for epilepsy with lamotrigine 2 mg/kg/d since 1996. In April 1998 she was admitted to the Rheumatology Unit for arthralgias affecting the small joints of the hands, wrists and knees, erythematosus skin rash and myalgias. She referred a vascular abnormality at the hands exposed to cold, compatible with Raynaud's phenomenon. Serum antinuclear antibodies (ANA) were positive (1:320, speckled pattern); moreover, a positivity for anti-Ro/SSA was observed. Rheumatoid factor was negative, serum complement was normal. LAC and anticardiolipin antibodies were negative. Drug-related lupus diagnosis was made with resolution of symptoms and gradual normalisation of positivity of ANA and anti-Ro/SSA upon lamotrigine withdrawal. To our knowledge, this is the first case report of an association between lamotrigine and the onset of SLE (systemic lupus erythematosus).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035425     DOI: 10.1177/096120330000900715

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  3 in total

1.  Lamotrigine-induced Systemic Lupus Erythematosus: A Diagnostic Dilemma.

Authors:  Jaskaran Batra; Sukhjot Kaur; Sandeep Kaushal; Aminder Singh
Journal:  Indian Dermatol Online J       Date:  2018 Nov-Dec

2.  Serologic Presentation of Lamotrigine-Induced Lupus.

Authors:  Hannah Dempsey; Gabriella Aitcheson; Gretchen Goble; Riley Snook
Journal:  Case Rep Neurol Med       Date:  2022-09-29

3.  Galactorrhea associated with juvenile systemic lupus erythematosus: a review of the role of prolactin.

Authors:  Tova Ronis; Ciarán M Duffy; Karen N Watanabe Duffy
Journal:  Pediatr Rheumatol Online J       Date:  2009-10-23       Impact factor: 3.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.